In vitro metabolism of (4-14C) pregnenolone in the ovaries of intact and HPL or HCG treated rats.
D006907:17-alpha-Hydroxypregnenolone / Q000096:biosynthesis; D000737:Androstenols / Q000096:biosynthesis; D000818:Animals; D002250:Carbon Radioisotopes; D006063:Chorionic Gonadotropin / Q000494:pharmacology*; D002854:Chromatography, Paper; D003687:Dehydroepiandrosterone / Q000096:biosynthesis; D004357:Drug Synergism; D004958:Estradiol / Q000096:biosynthesis; D004970:Estrone / Q000096:biosynthesis; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000096:biosynthesis; D007016:Hypophysectomy; D010053:Ovary / Q000187:drug effects / Q000378:metabolism*; D010928:Placental Lactogen / Q000494:pharmacology*; D011284:Pregnenolone / Q000378:metabolism*; D011374:Progesterone / Q000096:biosynthesis; D051381:Rats; D013256:Steroids / Q000096:biosynthesis; D013739:Testosterone / Q000096:biosynthesis
D000737:Androstenols; D002250:Carbon Radioisotopes; D006063:Chorionic Gonadotropin; D006908:Hydroxyprogesterones; D013256:Steroids; D004970:Estrone; D006907:17-alpha-Hydroxypregnenolone; D013739:Testosterone; D003687:Dehydroepiandrosterone; D011374:Progesterone; D004958:Estradiol; D011284:Pregnenolone; D010928:Placental Lactogen